EDGAR Filing Documents for 0001193125-22-156134

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-22-156134

Filing Date

2022-05-20

Accepted

2022-05-20 16:06:43

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d350430ds3.htm	S-3	406091
2	EX-1.2	d350430dex12.htm	EX-1.2	208509
3	EX-4.3	d350430dex43.htm	EX-4.3	33460
4	EX-4.4	d350430dex44.htm	EX-4.4	250541
5	EX-5.1	d350430dex51.htm	EX-5.1	35156
6	EX-23.1	d350430dex231.htm	EX-23.1	1265
7	EX-FILING FEES	d350430dexfilingfees.htm	EX-FILING FEES	56536
8	GRAPHIC	g350430g01a01.jpg	GRAPHIC	67283
9	GRAPHIC	g350430g01a02.jpg	GRAPHIC	58980
10	GRAPHIC	g350430g0519232110257.jpg	GRAPHIC	4291
	Complete submission text file	0001193125-22-156134.txt		1172907

Mailing Address 3 PRESTON COURT BEDFORD MA 01730

Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200

Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)